PHILADELPHIA - Taste deficits appear to be more prevalent among multiple sclerosis (MS) patients than previously reported and correlate with brain lesions left by the debilitating disease, a new study from the University of Pennsylvania's Smell and Taste Center and the department of Radiology found. The more lesions spotted on an MRI, the worse the taste function of the patient, the multi-institutional team reported in the Journal of Neurology.
The researchers, including lead author Richard Doty, PhD, director of Penn’s Smell and Taste Center and professor of Psychology in Otorhinolaryngology: Head and Neck Surgery at Penn’s Perelman School of Medicine, administered a standard taste test (sweet, sour, bitter, and salty) to 73 MS patients and 73 controls subjects, along with MRI of 52 brain regions known to be impacted by MS in both groups.
They found that the neurological disease significantly influenced the ability to identify tastes, especially salty and sweet. Fifteen to 32 percent of MS patients—which is nearly twice as high as previous studies found—had taste scores below the 5th percentile of controls. What’s more, taste scores were inversely correlated with lesion amounts and volumes in the large sectors of the frontal and temporal lobes, the higher regions of the brain, identified on the MRI.
“This study represents the most comprehensive study preformed to date on the influences of MS on the ability to taste,” Doty said. “It appears that a sizable number of these patients exhibit taste deficits, more so than originally thought. This suggests that altered taste function, though less noticeable than changes in vision, is a relatively common feature in MS.
“These findings give us a better insight about that relationship, as well as the areas of the brain that are more likely to impact the dysfunction when scarred from the disease.”
Common symptoms associated with MS include vision loss (optic neuritis), a hallmark symptom of MS, fatigue, facial pain and cognitive difficulties, among others; however, the connection between taste problems and MS is less clear and reportedly rare. Some studies put the number as low as five percent and as high as 20 percent, though many were self-reported accounts or included smaller number of patients with little detail about testing. Also, patients often mistake olfactory issues with taste problems, skewing the numbers. Importantly, the correlation between taste dysfunction and the myelin-related lesions—which are caused by the nerve damage from the disease—has not been made.
Isabelle A. Tourbier, a researcher in the department of Otolaryngology: Head and Neck Surgery and Smell and Taste Center at Penn, and Jayaram K. Udupa, PhD, chief of the Medical Imaging section in the department of Radiology at Penn, are co-authors on the study.
The team also included researchers from Johns Hopkins University, Michigan State University, Columbia University, Izmir Institute of Technology in Turkey, and the Henry Jackson Foundation.
MS affects the central nervous system, with more than 450,000 people in the United States living with the autoimmune disease, making it among the most common neurological illnesses in North America. Although MS can appear at any age, it most commonly begins between the ages of 20 and 40, and affects women twice as often as men.
For the taste tests, concentrations of each of the four tastes were pipetted on the left and right sides of the front and back of the tongue for a total of 96 tests for each of the participants. Each identified the taste (sweet, salt, bitter, sour) and graded each test on a scale from “very weak” to “very strong.”
Based on the tests, the percentage of MS patients with identification scores falling the below the 5th percentile of the controls was 15.07 percent for caffeine, 21.9 percent for citric acid, 24.66 percent for sucrose, and 31.50 percent for sodium chloride, the researchers found. Such scores were inversely correlated with lesion volumes in the brain, including temporal, medial frontal, and superior frontal lobes, and the number of lesions in the left and right superior frontal lobes, right anterior cingulate gyrus, and left parietal operculum.
Regardless of subject group, women outperformed men on taste measures, which mirrors what previous taste studies have found. It is likely due to the fact that women have more taste papillae and taste buds than men, the researchers note.
“Future studies investigating the relationship between taste and MS may help better diagnose and understand the disease, as well as better manage symptoms,” Doty said.
Co-authors include Dzung L. Pham, Jennifer L. XCuzzocreo, Bilge Karacali, Evan Beals, Laura Fabius, Fidias E. Leon-Sarmiento, Gul Moonis, Taehoon Kim, Toru Mihama, Rena J. Geckle, and David M. Yousem.
This study was funded by grants from the National Institutes of Health (R01 DC 02974, R01 NS 37172, and R01 NS070906).
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.
Department of Communications
For Patients and the General Public: